| Therapeutic vaccines for high-risk HPV-associated diseases A Chabeda, RJR Yanez, R Lamprecht, AE Meyers, EP Rybicki, II Hitzeroth Papillomavirus research 5, 46-58, 2018 | 222 | 2018 |
| Substitution of human papillomavirus type 16 L2 neutralizing epitopes into L1 surface loops: the effect on virus-like particle assembly and immunogenicity A Chabeda, AR Van Zyl, EP Rybicki, II Hitzeroth Frontiers in plant science 10, 439390, 2019 | 34 | 2019 |
| A plant-produced virus-like particle displaying envelope protein domain III elicits an immune response against West Nile virus in mice J Stander, A Chabeda, EP Rybicki, AE Meyers Frontiers in Plant Science 12, 738619, 2021 | 18 | 2021 |
| An optimized Factor H-Fc fusion protein against multidrug-resistant Neisseria gonorrhoeae J Shaughnessy, A Chabeda, Y Tran, B Zheng, N Nowak, C Steffens, ... Frontiers in Immunology 13, 975676, 2022 | 7 | 2022 |
| Optimizing a human papillomavirus type 16 L1-Based Chimaeric Gene for Expression in Plants II Hitzeroth, A Chabeda, MP Whitehead, M Graf, EP Rybicki Frontiers in Bioengineering and Biotechnology 6, 101, 2018 | 7 | 2018 |
| Therapeutic vaccines for high-risk HPV-associated diseases. Papillomavirus Res 5: 46–58 A Chabeda, RJR Yanez, R Lamprecht, AE Meyers, EP Rybicki, II Hitzeroth Epub 2017/12/27. https://doi. org/10.1016/j. pvr. 2017.12. 006. PubMed PMID …, 2018 | 7 | 2018 |
| Alternative pathway amplification and infections J Shaughnessy, A Chabeda, LA Lewis, S Ram Immunological Reviews 313 (1), 162-180, 2023 | 5 | 2023 |
| Therapeutic vaccines for high-risk HPV-associated diseases. Papillomavirus Res. 2018; 5: 46–58 A Chabeda, RJR Yanez, R Lamprecht, AE Meyers, EP Rybicki, II Hitzeroth Epub 2017/12/27. https://doi. org/10.1016/j. pvr. 2017.12. 006 PubMed …, 0 | 5 | |
| Development of complement factor H based immunotherapeutic molecules in tobacco plants against multidrug-resistant Neisseria gonorrhoeae J Shaughnessy, J Shaughnessy, A Chabeda, Y Tran, M James Maclean, ... MOLECULAR IMMUNOLOGY 141, 165-166, 2022 | | 2022 |
